Are the antidepressant effects of insulin-sensitizing medications related to improvements in metabolic markers?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2158-3188
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Are the antidepressant effects of insulin-sensitizing medications related to improvements in metabolic markers? ; volume:12 ; number:1 ; day:8 ; month:11 ; year:2022 ; pages:1-8 ; date:12.2022
Translational Psychiatry ; 12, Heft 1 (8.11.2022), 1-8, 12.2022
- Creator
-
Toba-Oluboka, Temi
Vochosková, Kristýna
Hajek, Tomas
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41398-022-02234-z
- URN
-
urn:nbn:de:101:1-2023012210543826811153
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Toba-Oluboka, Temi
- Vochosková, Kristýna
- Hajek, Tomas
- SpringerLink (Online service)
Other Objects (12)
Depression, antidepressant medications, and risk of Clostridium difficileinfection
Gender and race disparities in weight gain among offenders prescribed antidepressant and antipsychotic medications
Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic Action
Fructose, insulin resistance, and metabolic dyslipidemia
Second-generation antipsychotic medications and metabolic disturbance in children and adolescents
Neuroanatomical dimensions in medication-free individuals with major depressive disorder and treatment response to SSRI antidepressant medications or placebo
Metabolic patterns in insulin-sensitive male hypogonadism
Metabolic patterns in insulin-resistant male hypogonadism
Healthcare professionals’ perceptions on the emotional impact of having an inadequate response to antidepressant medications: survey and prospective patient audit
Use of antidepressant medications among older adults in European long-term care facilities: a cross-sectional analysis from the SHELTER study
Publisher Correction: Neuroanatomical dimensions in medication-free individuals with major depressive disorder and treatment response to SSRI antidepressant medications or placebo
Genetics of Insulin Resistance and the Metabolic Syndrome
Depression, antidepressant medications, and risk of Clostridium difficileinfection
Gender and race disparities in weight gain among offenders prescribed antidepressant and antipsychotic medications
Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic Action
Fructose, insulin resistance, and metabolic dyslipidemia
Second-generation antipsychotic medications and metabolic disturbance in children and adolescents
Neuroanatomical dimensions in medication-free individuals with major depressive disorder and treatment response to SSRI antidepressant medications or placebo
Metabolic patterns in insulin-sensitive male hypogonadism
Metabolic patterns in insulin-resistant male hypogonadism
Healthcare professionals’ perceptions on the emotional impact of having an inadequate response to antidepressant medications: survey and prospective patient audit
Use of antidepressant medications among older adults in European long-term care facilities: a cross-sectional analysis from the SHELTER study
Publisher Correction: Neuroanatomical dimensions in medication-free individuals with major depressive disorder and treatment response to SSRI antidepressant medications or placebo
Genetics of Insulin Resistance and the Metabolic Syndrome
Depression, antidepressant medications, and risk of Clostridium difficileinfection
Gender and race disparities in weight gain among offenders prescribed antidepressant and antipsychotic medications
Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic Action
Fructose, insulin resistance, and metabolic dyslipidemia
Second-generation antipsychotic medications and metabolic disturbance in children and adolescents
Neuroanatomical dimensions in medication-free individuals with major depressive disorder and treatment response to SSRI antidepressant medications or placebo
Metabolic patterns in insulin-sensitive male hypogonadism
Metabolic patterns in insulin-resistant male hypogonadism
Healthcare professionals’ perceptions on the emotional impact of having an inadequate response to antidepressant medications: survey and prospective patient audit
Use of antidepressant medications among older adults in European long-term care facilities: a cross-sectional analysis from the SHELTER study
Publisher Correction: Neuroanatomical dimensions in medication-free individuals with major depressive disorder and treatment response to SSRI antidepressant medications or placebo